Distribution of Cyclosporin in Organ Transplant Recipients

By Akhlaghi F.  

Clinical Pharmacokinetics, Vol. 41, Iss. 9, 2002-01 ,pp. : 615-637

Adis International

Access to resources Recommend Favorite

Induction Immunosuppression in Kidney Transplant Recipients Older than 60 Years of Age: Safety and Efficacy of ATGAM®, OKT3® and Simulect®

By Michael Heifets   Muhammad I. Saeed   Mitten H. Parikh   Debra Sierka   Mysore S.A. Kumar  

Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. : 747-756

Adis International

Access to resources Recommend Favorite

The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients

By  

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 1941-1952

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions Between Cyclosporin and Lipid-Lowering Drugs: Implications for Organ Transplant Recipients

By åsberg A.  

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 367-378

Adis International

Access to resources Recommend Favorite

Conversion from Cyclosporin to Tacrolimus in Paediatric Liver Transplant Recipients

By Mazariegos G.V.  

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 661-672

Adis International

Access to resources Recommend Favorite